CLINICAL_TRIALS
trial_result
· 2017-01-10
Clinical Trial Update: Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation [Phase 2]
Summary
Phase 2 study evaluating Cavosonstat (N91115) in cystic fibrosis patients homozygous for the F508del-CFTR mutation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nivalis Therapeutics, Inc. | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED